Philip Sturno Email & Phone Number

New York, Ny, Us

Bridgewater, New Jersey

Lead 3 direct reports located in Poland, Mexico, and Colombia and 70+ downline reports to manage R&D portfolio of 20 licensed generic pharmaceutical products. Direct portfolio expansion, in-house R&D development, and resolution of plant technical production issues. Report to Chief Medical Officer (CMO).R&D LEADERSHIP: Meet with Sr Dir. of Business Development, R& D Managers, and Plant Manager regularly to update on R&D portfolio, including key deliverables and status of current and proposed programs and projects.PORTFOLIO EXPANSION, BUSINESS DEVELOPMENT & PRODUCT STRATEGY: Instrumental product leader to deliver input on capability for strategy in Eastern Europe, Mexico, and Colombia; set specific product feasibility expectations in specific markets.R&D IN-HOUSE DEVELOPMENT: Supervise 35 team members to support in-house R&D development.PRODUCTION ISSUES RESOLUTION: Motivate 45 team members to resolve product-related technical issues within the plant.PRODUCT QUALITY: Oversaw technical review of development partner’s product dossiers to resolve issues impacting regulatory approval and launch success.LAUNCH PLANNING: Built launch planning capability and dedicated Project Management team from ground up with product diligence for new product dossiers, launch supply checklists, and contract manufacturing organizations (CMOs) formal relationship management processes.

Bridgewater, New Jersey

Managed 9 direct and 250 global downline reports to deliver innovation and product development for Bausch & Lomb Pharmaceutical, Surgical, and Consumer Product businesses, Solta Medical, and Salix Pharmaceuticals. Set strategy for formulation/analytical development, technical operations, project management, and engineering. Reported to Chief Medical Officer (CMO).EXECUTIVE ENGAGEMENT: Led portfolio review meetings with EVP Sales & Marketing, VP Regulatory, and plant operations leadership regularly. Member of Medical Device Regulations Steering Committee (to meet EU requirements). BUSINESS STRATEGY: Advised VPs Commercial and Regulatory, R&D leads, project teams, and Lead Engineers in product strategy.PRODUCT PORTFOLIO: Co-defined product portfolio with VP Commercial.REGULATORY: Partnered with Regulatory to identify regulatory pathways and submissions and remediation of compliance gaps.PRODUCT & CONTRACT TECHNICAL SUBJECT MATTER EXPERT (SME): As technical SME, delivered insight on deal structures, market opportunities, and business impact issues.B+L BUSINESS REFOCUS & LEADERSHIP: Refocused efforts across 7 lines of business, including Ophthalmic pharmaceutical development, Ophthalmic surgical equipment and handpieces (cornea, cataract, retina), energy devices for aesthetic dermatology treatments, and pharmaceutical product development for GI products.MEDICAL DEVICE DIRECTION: Created product vision and oversaw Project Management and engineering teams.PHARMACEUTICAL DIRECTION: Set strategy approaches and supervised Formulation & Analytical Development, Process Development, Technical Operations, and Project Management teams. Created global pharmaceutical R&D team.THERMAGE DEVICE RE-DESIGN: Identified issues with existing Thermage device internal wiring. Worked with Engineering to redesign system delivering minimal wiring requirements.

Bridgewater, New Jersey

Managed 160-person R&D organization across 7 USA sites supporting pharmaceutical, consumer, and medical device programs. Oversaw formulation/analytical development, technical operations, project management, and engineering. Managed USA R&D alliances.ACQUISITION INTEGRATION LEADERSHIP: Achieved target R&D operational synergies for 6 major acquisitions.

Bridgewater, New Jersey

Directed functional development of 2 compounds for treatment of Tourette’s Syndrome and Levodopa-induced Parkinson's dyskinesia.

Worked with Founders and CEO to create product development and commercialization strategies for a product designed to diagnose and treat neurologically impaired patients.

Led cross-functional team to identify potential EXJADE risks for specific subpopulations. Developed re-formulation strategy to improve patient compliance and gastrointestinal tolerability.

Built a 16-member global planning and budgeting organization managing 26 clinical programs from Exploratory Development through Phase IV.Drove year-end spending variances down from 25% to 1% for four consecutive years by leading Six Sigma Greenbelt teams focused on improving trial and financial planning processes.

Led 23 member clinical database development organization which launched 50 web-based clinical trials in 35 countries.

Managed technical transfer activities for a $17.5M global implementation of a web-based clinical data management system (Inform). Delivered project on time and within budget.

Developed cost-benefit analysis and gained executive approval for a $17.5M web-based clinical data management system.

Founding team member of value-based management and supply chain strategy consulting practice.

Reengineered customer service, forecasting and order management processes for a pharmaceutical packaging company. Recommendations identified annual savings of $5M.

Managed 60 member multi-functional packaging team consisting of aseptic, blister, bottle, liquid, and powder packaging operations.

Designed autopilot for first successful launch of Atlas/Centaur rocket.

Mba, Finance, Operations

Bachelor’S Degree, Mechanical Engineering